The future is now...
https://sickplugger.com

Artist ϟ Producer ϟ Engineer ϟ Full Sail University 
Contact & Submisisons: misfitsubmit@gmail.com
Follow me @danielthemisfit everywhere

Streaming on Mondays, Wednesdays and Thursdays at 6pm GMT on: https://www.twitch.tv/sekaitunes

Business and Commissions/Ghost production: tiago@sekaitunes.com

Known to many as Sekai, Tiago Salvador is a musician from the beaches of rural Portugal. They have a decade of music production under their belt, exploring genres ranging from dubstep and future bass to pop and R&B. 

What started as a solo project with the hope of connecting to others quickly became a declaration of self-expression, as Tiago began incorporating their vocals and lyricism into tracks featured on NoCopyrightSounds, Disciple, Odio Records and MA Music. Throughout their career they worked with talented acts such as Chime, Whales and Rob Gasser; producing tracks that anyone can dance to, while singing about deeply personal experiences of love and heartbreak.

Currently, Sekai continues to flourish as an indie singer/songwriter, making lovesick pieces that fit right into a pop playlist, but still retain the unmistakable production techniques found in EDM. Tracks such as ILY, Sway, and Mirror are among the first singles from this new catalogue, with countless more slated to release.

The world is my canvas.

Submit original tracks via message.

nycliverecords@gmail.com

We love all genres. 
Platform for independent artists worldwide!
Submit: https://sick-taste.com

Miquela - "Hard Feelings" + "Handful" available now at https://miquela.ffm.to/hardfeelings

We are CyberPixl, the label of the scene.
Our Discord community: https://discord.gg/QyjHET3

Submissions for our label go here: https://goo.gl/forms/TJp6OLsJYwQ1ZKn03

We seek to create fairness in the art world,
giving talented hard working artists the traction, audience and money they deserve through a platform that inspires and helps out in the whole process every step of the way.

https://cyberpixl.com/

DISARMED is following